store

  • Antigen Peptide EBV EBNA3C - HLA-B*44:05 (EENLLDFVRF)

    Antigen Peptide EBV EBNA3C – HLA-B*44:05 (EENLLDFVRF)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-EENLLDFVRF-OH

  • Antigen Peptide EBV EBNA3C - HLA-DQB1*05:01 (SDDELPYIDPNMEPV)

    Antigen Peptide EBV EBNA3C – HLA-DQB1*05:01 (SDDELPYIDPNMEPV)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SDDELPYIDPNMEPV-OH

  • Antigen Peptide EBV EBNA3C - HLA-DRB1*01:01 (PAPQAPYQGYQEPPAPQAPY)

    Antigen Peptide EBV EBNA3C – HLA-DRB1*01:01 (PAPQAPYQGYQEPPAPQAPY)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-PAPQAPYQGYQEPPAPQAPY-OH

  • Antigen Peptide EBV EBNA4 HLA-A*1101 (AVFDRKSDAK)

    Antigen Peptide EBV EBNA4 HLA-A*1101 (AVFDRKSDAK)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-AVFDRKSDAK-OH Specifications: 10mer peptide as TFA salt

  • Antigen Peptide EBV gB HLA-A*0201 (FLDKGTYTL)

    Antigen Peptide EBV gB HLA-A*0201 (FLDKGTYTL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Envelope protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FLDKGTYTL-OH Specifications: 9mer peptide as TFA salt

  • Antigen Peptide EBV LMP1 - HLA-B*57:01 (IALYLQQNW)

    Antigen Peptide EBV LMP1 – HLA-B*57:01 (IALYLQQNW)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 1 (LMP1) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-IALYLQQNW-OH

  • Antigen Peptide EBV LMP1 HLA-A*0201 (YLQQNWWTL)

    Antigen Peptide EBV LMP1 HLA-A*0201 (YLQQNWWTL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 1 (LMP1) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YLQQNWWTL-OH Specifications: 9mer peptide as TFA salt

  • Antigen Peptide EBV LMP2 - HLA-B*27:05 (RRRWRRLTV)

    Antigen Peptide EBV LMP2 – HLA-B*27:05 (RRRWRRLTV)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 2 (LMP2) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RRRWRRLTV-OH

  • Antigen Peptide EBV-LMP1 HLA-A*0201 (YLLEMLWRL)

    Antigen Peptide EBV-LMP1 HLA-A*0201 (YLLEMLWRL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 1 (LMP1) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YLLEMLWRL-OH Specifications: 9mer peptide as TFA salt

  • Antigen Peptide Envelope glycoprotein H-2 Kb (SSIEFARL)

    Antigen Peptide Envelope glycoprotein H-2 Kb (SSIEFARL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes, Oral Herpes Layout: Freeze-dried in plastic vial Organism: Herpes Simplex Virus Protein Name: Envelope protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SSIEFARL-OH Specifications: 8mer peptide as TFA salt

  • Antigen Peptide Envelope glycoprotein H-2 Ld (SPSYVYHQF)

    Antigen Peptide Envelope glycoprotein H-2 Ld (SPSYVYHQF)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Cancer, Leukemia Layout: Freeze-dried in plastic vial Organism: Murine Leukemia Virus (MoMLV) Protein Name: Envelope protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SPSYVYHQF-OH Specifications: 9mer peptide as TFA salt

  • Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

    Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease Layout: Freeze-dried in plastic vial Organism: Human Protein Name: Envelope protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-QIFEASKAHL-OH Specifications: 10mer peptide as TFA salt

  • Antigen Peptide ERBB2 H-2 Kd (TYLPTNASL)

    Antigen Peptide ERBB2 H-2 Kd (TYLPTNASL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Breast cancer, Cancer, Gastric cancer, Glioma, Malignant genital cancers Layout: Freeze-dried in plastic vial Organism: Human Protein Name: ErbB-2 receptor tyrosin-protein kinase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-TYLPTNASL-OH Specifications: 9mer peptide as TFA salt

  • Antigen Peptide ERBB2 HLA-A*0201 (KIFGSLAFL)

    Antigen Peptide ERBB2 HLA-A*0201 (KIFGSLAFL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Cancer Layout: Freeze-dried in plastic vial Organism: Human Protein Name: ErbB-2 receptor tyrosin-protein kinase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-KIFGSLAFL-OH Specifications: 9mer peptide as TFA salt

  • Antigen Peptide ERBB2 HLA-A*0201 (RLLQETELV)

    Antigen Peptide ERBB2 HLA-A*0201 (RLLQETELV)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Cancer Layout: Freeze-dried in plastic vial Organism: Human Protein Name: ErbB-2 receptor tyrosin-protein kinase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RLLQETELV-OH Specifications: 9mer peptide as TFA salt

  • Antigen Peptide Fibromodulin HLA-A*0201 (LLLAGLFSL)

    Antigen Peptide Fibromodulin HLA-A*0201 (LLLAGLFSL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Aging, Cancer Layout: Freeze-dried in plastic vial Organism: Human Protein Name: Fibromodulin Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LLLAGLFSL-OH Specifications: 9mer peptide as TFA salt